Cargando…

SY-707, an ALK/FAK/IGF1R inhibitor, suppresses growth and metastasis of breast cancer cells: SY-707 is an ALK/FAK/IGF1R inhibitor

Focal adhesion kinase (FAK), a multi-functional cytoplasmic tyrosine kinase, plays a critical role in cancer migration, proliferation and metastasis via regulating multiple signaling pathways. SY-707 is an anaplastic lymphoma kinase (ALK)/FAK/type 1 insulin-like growth factor receptor (IGF1R) multi-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Ping, Sun, Yinghui, Liu, Shuang, Niu, Jing, Liu, Xijie, Chu, Qiaoyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909315/ https://www.ncbi.nlm.nih.gov/pubmed/35538024 http://dx.doi.org/10.3724/abbs.2022008

Ejemplares similares

Rationale for co-targeting IGF-1R and ALK in ALK fusion positive lung cancer
por: Lovly, Christine M., et al.
Publicado: (2014)

Pharmacological profiling of a dual FAK/IGF-1R kinase inhibitor TAE226 in cellular and in vivo tumor models
por: Fukami, Shigemi, et al.
Publicado: (2019)

IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK
por: Lehman, Christine E., et al.
Publicado: (2021)

Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study
por: Xing, Puyuan, et al.
Publicado: (2022)

ALK and IGF-1R as independent targets in crizotinib resistant lung cancer
por: Wilson, Christabel, et al.
Publicado: (2017)

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2020)

LTK and ALK promote neuronal polarity and cortical migration by inhibiting IGF1R activity
por: Christova, Tania, et al.
Publicado: (2023)

PacCYP707A2 negatively regulates cherry fruit ripening while PacCYP707A1 mediates drought tolerance
por: Li, Qian, et al.
Publicado: (2015)

miR-186-5p Promotes Apoptosis by Targeting IGF-1 in SH-SY5Y OGD/R Model
por: Wang, Rui, et al.
Publicado: (2018)

FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells
por: Taliaferro-Smith, LaTonia, et al.
Publicado: (2015)

Synergism of FAK and ROS1 inhibitors in the treatment of CDH1-deficient cancers mediated by FAK-YAP signaling
por: Gao, Jiaming, et al.
Publicado: (2023)

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2019)

707. Molecular Epidemiology of Clostridioides difficile Colonization in Families with Infants
por: Toltzis, Philip, et al.
Publicado: (2023)

ALK Inhibitors in the Treatment of ALK Positive NSCLC
por: Khan, Muhammad, et al.
Publicado: (2019)

Correction: Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK(+) T-cell lymphoma
por: George, Bhawana, et al.
Publicado: (2023)

Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models
por: Fang, Douglas D., et al.
Publicado: (2022)

CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018)

PT707. Transcriptome analysis in Tsc2 heterozygous knockout mice
por: Kasai, Shinya, et al.
Publicado: (2016)

707. QPX9003: Pharmacology of a Novel Polymyxin in Mice and Rats
por: Sabet, Mojgan, et al.
Publicado: (2019)

707. Infective Endocarditis and Medication Assisted Treatment in Opioid Use Disorder
por: Loomis, Katherine, et al.
Publicado: (2020)

ALK and NSCLC: Targeted therapy with ALK inhibitors
por: Hallberg, Bengt, et al.
Publicado: (2011)

Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma
por: Prenen, Hans, et al.
Publicado: (2015)

Systeme T.700 (T.704. T.705 T.706 T.707 T.708) dossier d'installation
por: Debordes, R
Publicado: (1976)

Electron Stimulated Molecular Desorption of a NEG St 707 at Room Temperature
por: Le Pimpec, F, et al.
Publicado: (2001)

707 Rapid Identification of Pathogens Causing Septic Arthritis using FilmArray®
por: Sanderson, Susan K., et al.
Publicado: (2014)

MON-707 Improving Screening for Diabetic Retinopathy in a Resident Based Clinic
por: Tofil, Kathrin Sandra, et al.
Publicado: (2020)

SY-1530, a highly selective BTK inhibitor, effectively treats B-cell malignancies by blocking B-cell activation
por: Wang, Liao, et al.
Publicado: (2022)

IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway
por: Guan, Jikui, et al.
Publicado: (2023)

Correction: Rigiracciolo, D.C., et al., IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells 2020, 9, 1010
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2020)

miR-135a inhibits tumor metastasis and angiogenesis by targeting FAK pathway
por: Cheng, Zhenguo, et al.
Publicado: (2017)

Immunoassays for the quantification of ALK and phosphorylated ALK support the evaluation of on‐target ALK inhibitors in neuroblastoma
por: Tucker, Elizabeth R., et al.
Publicado: (2017)

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017)

SUMOylation at K(707) of DGCR8 controls direct function of primary microRNA
por: Zhu, Changhong, et al.
Publicado: (2015)

The Role of cheA Genes in Swarming and Swimming Motility of Pseudomonas pseudoalcaligenes KF707
por: Fedi, Stefano, et al.
Publicado: (2016)

Effective natural inhibitors targeting IGF-1R by computational study
por: Wang, Xinyu, et al.
Publicado: (2022)

Discovery of novel 2-aminopyridine derivatives as ROS1 and ALK dual inhibitors to combat drug-resistant mutants including ROS1(G2032R) and ALK(G1202R)
por: Liu, Siming, et al.
Publicado: (2023)

ALK Rearrangement–Positive Pancreatic Cancer with Brain Metastasis Has Remarkable Response to ALK Inhibitors: A Case Report
por: Ou, Kai, et al.
Publicado: (2021)

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK(+) T-cell lymphoma
por: Vishwamitra, Deeksha, et al.
Publicado: (2015)

Does Reduced IGF-1R Signaling in Igf1r (+/−) Mice Alter Aging?
por: Bokov, Alex F., et al.
Publicado: (2011)

CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
por: Chen, Zibo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dsjrmdkpcsus587acrvqu8k1bt